Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Operating Expenses | 11,907 | 8,982 | 13,300 | 6,261 | 6,424 |
| Operating Income | -11,907 | -8,982 | -13,300 | -6,261 | -6,424 |
| Other Income | 54 | 25 | 40 | 53 | 34 |
| Pre-tax Income | -11,853 | -8,957 | -13,260 | -6,208 | -6,390 |
| Net Income Continuous | -11,853 | -8,957 | -13,260 | -6,208 | -6,390 |
| Net Income | $-11,853 | $-8,957 | $-13,260 | $-6,208 | $-6,390 |
| EPS Basic Total Ops | -85.80 | -64.75 | -95.51 | 3,331.63 | -438.71 |
| EPS Basic Continuous Ops | -85.13 | -64.67 | -95.90 | 3,331.70 | -438.89 |
| EPS Diluted Total Ops | -85.80 | -64.75 | -95.51 | 3,331.63 | -438.71 |
| EPS Diluted Continuous Ops | -85.13 | -64.67 | -95.90 | 3,331.70 | -438.89 |
| EBITDA(a) | $-11,842 | $-8,965 | $-13,295 | $-6,256 | $-6,419 |